Sin conexión a internet: se muestra la versión guardada de la página.

The Cooper Compan…

USUSD
← Al Screener

The Cooper Companies, Inc (LSE:0I3I) — Ophthalmic Goods. Número de bolsas en las que cotizan las acciones de la empresa: 4. En esta página: cotización y gráfico, dividendos, principales accionistas e historial del número de acciones.

⚠ No los confundas: hay otra empresa con el mismo nombre o uno muy similar. Es un registro aparte — comprueba el ticker, el número de bolsa y el número de registro.

Sobre la Empresa

Sitio Web
coopercos.com
Relaciones con los Inversores
investor.coopercos.com/
Sector
Health Care · Ophthalmic Goods
Sede Central
SAN RAMON, United States
Consejero Delegado
Albert G. White
Empleados
15 000
Fundada
1958
Cotiza Desde
29.01.2018 (LSE:0I3I)
Acciones en Circulación
190.16 M a 2026-09-03
Capital Flotante
188.77 M
Capitalización Bursátil
10.77 mil M USD
Insiders
0.63%
Inversores Institucionales
111.92%
Industria (SIC)
Ophthalmic Goods
Forma Jurídica
XTIQ
ISIN
US2166484020
LEI
QJKMVPIGLH7530PCUE20
P/E
3.0
Ratio de Reparto
0%
FCF
678 M USD
Deuda
2.54 mil M USD
3.5 a. de FCF
Racha de Dividendos
—
Beneficios, FCF y dividendos pagados — para los 12 meses hasta 31.07.2026 (el último informe de la compañía).
NAV
43.81 USD · P/NAV 1.28
Fecha del Balance31.07.2026
Activos12.7 mil M USD
− Pasivos4.35 mil M USD
= Patrimonio Total8.33 mil M USD
− Participaciones No Dominantes200 mil USD
= NAV (patrimonio de los accionistas de la empresa)8.33 mil M USD
− Fondo de Comercio3.88 mil M USD
− Activos Intangibles1.45 mil M USD
= NAV Tangible3.01 mil M USD
Acciones190 100 000
NAV por Acción43.81 USD
NAV Tangible por Acción15.81 USD
Precio de la Acción (0I3I)56.1550 USD
P/NAV1.28
Historial del NAV
Fecha del BalanceNAVNAV por Acción
31.07.20268.33 mil M USD43.81 USD
30.04.20268.24 mil M USD42.27 USD
31.01.20268.36 mil M USD42.87 USD
31.10.20258.24 mil M USD42.06 USD
31.07.20258.35 mil M USD42.02 USD
30.04.20258.29 mil M USD41.54 USD
31.01.20258.13 mil M USD40.66 USD
31.10.20248.08 mil M USD40.50 USD
Descripción

The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.

anuncio

Bolsas y Tickers

BolsaTickerMonedaPrecioTipo
US USA StocksCOO principalUSD54.88 +0.53%acciones ordinarias
LSE London Stock Exchange0I3I IOBUSD56.155 +0.00%acciones ordinarias
MI Borsa Italiana (Milan)1COO secundariaEUR48.72 -0.46%acciones ordinarias
XETRA XetraCP60 secundariaEUR50.43 +0.89%acciones ordinarias

Precio en 3 Meses

día alcista día bajista fecha ex-dividendo fecha de pagoPasa el cursor / toca un día — precios de apertura, cierre, máximo y mínimo

Dividendos

Fecha ExPagoImporte%TipoTicker
2023-07-26—0.0300 USD0.1/0.1 %—LSE:0I3I

Principales Accionistas

TitularParticipaciónAccionesFecha del Informe
Blackrock Inc.7.9%15.03 M2026-06-30
Vanguard Capital Managem…6.71%12.76 M2026-06-30
State Street Corporation4.68%8.89 M2026-06-30
Vanguard Portfolio Manag…4.56%8.67 M2026-06-30
T. Rowe Price Investment…3.91%7.43 M2026-06-30
Browning West Lp3.78%7.2 M2026-06-30
VANGUARD INDEX FUNDS-Van…3.26%6.19 M2026-06-30
Price (T.Rowe) Associate…2.93%5.58 M2026-06-30
Kayne Anderson Rudnick I…2.86%5.43 M2026-06-30
Geode Capital Management…2.82%5.36 M2026-06-30
Franklin Resources, Inc.2.68%5.1 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.66%5.06 M2026-06-30
VANGUARD INDEX FUNDS-Van…2.35%4.47 M2026-06-30
T. Rowe Price Mid-Cap Gr…2.04%3.88 M2026-06-30
VANGUARD INDEX FUNDS-Van…1.49%2.83 M2026-06-30
Invesco Exchange-Traded…1.47%2.79 M2026-08-31
T. Rowe Price Mid-Cap Va…1.45%2.76 M2026-06-30
iShares Trust-iShares Co…1.37%2.6 M2026-08-31
JANUS INVESTMENT FUND-Ja…1.33%2.52 M2026-06-30
Fidelity Concord Street…1.33%2.52 M2026-07-31
WEISS ROBERT S (Director…≈0.29%550 4592026-04-01
WHITE ALBERT G III (Chie…≈0.13%245 0722026-01-08
MCBRIDE DANIEL G (Chief…≈0.09%163 8482026-01-08
SHEFFIELD HOLLY R (Offic…≈0.02%43 2612026-01-08
JAY COLLEEN E (Director)≈0.02%39 9072026-04-01
KOZY WILLIAM A (Director…≈0.02%31 1492025-04-01
KURZIUS LAWRENCE ERIK (D…≈0.02%31 0992026-09-16
ANDREWS BRIAN G (Chief F…≈0.02%30 7282026-01-08
WARNER GERARD H, III (Of…≈0.01%23 8522026-01-08
ROSEBROUGH WALTER M JR (…——2026-09-14